Zobrazeno 1 - 10
of 1 266
pro vyhledávání: '"NOVICK, D."'
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 14, Pp 2473-2484 (2018)
Jia Huang,1 Yun Wang,1 Jun Chen,1 Yanlei Zhang,2 Zheng Yuan,2 Li Yue,2 Josep Maria Haro,3 Maria Victoria Moneta,3 Diego Novick,4 Yiru Fang1,5,6 1Division of Mood Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medici
Externí odkaz:
https://doaj.org/article/bb7b29fd6d9e4e7ba39a12595ce76382
Publikováno v:
Patient Preference and Adherence, Vol Volume 11, Pp 1859-1868 (2017)
Diego Novick,1 William Montgomery,2 Ellen Vorstenbosch,3 Maria Victoria Moneta,3 Héctor Dueñas,4 Josep Maria Haro3 1Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia; 3Parc Sanitari Sant Joan de
Externí odkaz:
https://doaj.org/article/34f935e810c4463e8c655ae6d59965bc
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Patient Preference and Adherence, Vol Volume 11, Pp 1019-1025 (2017)
Diego Novick,1 William Montgomery,2 Tamas Treuer,3 Ai Koyanagi,4 Jaume Aguado,4 Susanne Kraemer,5 Josep Maria Haro4 1Global Patient Outcomes and Real World Evidence (GPORWE), Eli Lilly and Company, Windlesham, Surrey, UK; 2Global Patient Outcomes and
Externí odkaz:
https://doaj.org/article/ed0c4aee490640f18b7640290271d3cb
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol Volume 12, Pp 2927-2939 (2016)
Diego Novick,1 William Montgomery,2 Tamas Treuer,3 Maria Victoria Moneta,4 Josep Maria Haro4 1Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia; 3Eli Lilly and Company, Neuroscience Research, Budap
Externí odkaz:
https://doaj.org/article/31853c122c8e4fdf878927e63784e87a
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2016, Iss Issue 1, Pp 795-800 (2016)
Diego Novick,1 William Montgomery,2 Jaume Aguado,3 Xiaomei Peng,4 Josep Maria Haro3 1Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly Australia Pty Ltd, West Ryde, NSW, Australia; 3Parc Sanitari Sant Joan de Déu, CIBERSAM, Universitat de Ba
Externí odkaz:
https://doaj.org/article/16f1b2e52b314808bd30af1d6b43360a
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2016, Iss Issue 1, Pp 383-392 (2016)
Diego Novick,1 William Montgomery,2 Josep Maria Haro,3 Maria Victoria Moneta,3 Gang Zhu,4 Li Yue,5 Jihyung Hong,6 Héctor Dueñas,7 Roberto Brugnoli8 1Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly Australia Pty Ltd, West Ryde, NSW, Austra
Externí odkaz:
https://doaj.org/article/817d96775c9744fba77c329c4524847d
Publikováno v:
Patient Preference and Adherence, Vol 2015, Iss default, Pp 1481-1490 (2015)
Jihyung Hong,1 Diego Novick,1 William Montgomery,2 Maria Victoria Moneta,3 Héctor Dueñas,4 Xiaomei Peng,5 Josep Maria Haro3 1Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly Australia Pty Ltd, Sydney, NSW, Australia; 3Parc Sanitari Sant Jo
Externí odkaz:
https://doaj.org/article/af72267eeecc4adcb5b6f994290edec7
Publikováno v:
Patient Preference and Adherence, Vol 2015, Iss default, Pp 421-428 (2015)
Diego Novick,1 William Montgomery,2 Victoria Moneta,3 Xiaomei Peng,4 Roberto Brugnoli,5 Josep Maria Haro3 1Eli Lilly and Company, Windlesham, Surrey, UK; 2Eli Lilly Australia Pty Ltd, West Ryde, Australia; 3Parc Sanitari Sant Joan de Déu, CIBERSAM,
Externí odkaz:
https://doaj.org/article/b75db21340e647a99f84dff62096f7c6
Publikováno v:
Neuropsychiatric Disease and Treatment, Vol 2015, Iss default, Pp 197-205 (2015)
Diego Novick,1 Jihyung Hong,1 William Montgomery,2 Héctor Dueñas,3 Magdy Gado,4 Josep Maria Haro5 1Eli Lilly and Company, Windlesham, UK; 2Eli Lilly Australia Pty Ltd, West Ryde, Australia; 3Eli Lilly de Mexico, Mexico City, Mexico; 4Eli Lilly and
Externí odkaz:
https://doaj.org/article/021e8ad80d89430daccb3c0894f13687